ctA, lncRNA:flamA has partially lethal - majority live phenotype, enhanceable by AstC-R2[+]/AstC-R2f03116
ctA, lncRNA:flamA has partially lethal - majority live phenotype, suppressible by AGO3[+]/AGO2414/AGO3t2/AGO2[+]
ctA, lncRNA:flamA has partially lethal - majority live phenotype, suppressible by Su(var)3-7DG10405/Su(var)3-7[+]
ctA, lncRNA:flamA has partially lethal - majority live phenotype, suppressible | partially by Su(var)2055/Su(var)205[+]
ctA, lncRNA:flamA has partially lethal - majority live phenotype, suppressible by Su(var)3-91/Su(var)3-9[+]
ctA, lncRNA:flamA has partially lethal - majority live phenotype, suppressible | partially by Su(var)3-9[+]/Su(var)3-92
ctA, lncRNA:flamA has partially lethal - majority live phenotype, suppressible | partially by AGO2414/AGO2[+]
ctA, lncRNA:flamA has partially lethal - majority live phenotype, suppressible | partially by Dcr-2[+]/Dcr-2L811fsX
ctA, lncRNA:flamA has partially lethal - majority live phenotype, suppressible | partially by AGO3[+]/AGO3t2
ctA, lncRNA:flamA has partially lethal - majority live phenotype, suppressible | partially by aub[+]/aubHN2
ctA, lncRNA:flamA has partially lethal - majority live phenotype
AstC-R2f03116, ct[+]/ctA, lncRNA:flamA has partially lethal - majority live phenotype
AstC-R2f03116, ctA, lncRNA:flamA has lethal - all die before end of P-stage phenotype
ct[+]/ctA, fA/f[+], lncRNA:flamA has increased mortality phenotype
ctA, lncRNA:flamBG02658 has partially lethal - majority live phenotype
ct6/ctA, lncRNA:flam1/lncRNA:flamA has increased mortality phenotype
su(Hw)8 homozygozity suppresses the cut-wing defects exhibited by ctA homozygotes.
Both flamBG02658,vctA double homozygotes and flamA/flamA, AstC-R2f03116/AstC-R2f03116, ctA/+ mutants present significant mortality during the pharate stage, as compared to controls.
flamA, ctA double homozygotes display significant mortality during the pharate stage as compared to controls, which is significantly increased or even reaches full lethality by AstC-R2f03116 heterozygosity or homozygosity, respectively; these flamA, ctA, AstC-R2f03116 triple homozygous lethal pharates become trapped in the pupal case, still exhibiting pupal membrane attached to several body parts; the mortality of flamA, ctA double homozygotes is suppressed by heterozygosity for either Su(var)3-7DG10405, Su(var)2055, Su(var)3-91, Su(var)3-92, AGO2414, Dcr-2L811fsX, AGO3t2 or aubHN2, or by AGO2414, AGO3t2 double heterozygosity; flamA/flam1, ctA/ct6 double transheterozygotes show a small but significant increase in mortality as compared to flamA/flam1 single heterozygotes.
flamA homozygotes also double transheterozygous for ctA and fA exhibit a small but significant increase in pharate mortality, as compared to controls.